Skip to main content
Top
Published in: BMC Cancer 1/2005

Open Access 01-12-2005 | Case report

Hodgkin's disease as unusual presentation of post-transplant lymphoproliferative disorder after autologous hematopoietic cell transplantation for malignant glioma

Authors: Alberto Zambelli, Daniele Lilleri, Fausto Baldanti, Mario Scelsi, Laura Villani, Gian Antonio Da Prada

Published in: BMC Cancer | Issue 1/2005

Login to get access

Abstract

Background

Post-transplant lymphoproliferative disorder (PTLD) is a complication of solid organ and allogeneic hematopoietic stem cell transplantation (HSCT); following autologous HSCT only rare cases of PTLD have been reported.
Here, a case of Hodgkin's disease (HD), as unusual presentation of PTLD after autologous HSCT for malignant glioma is described.

Case presentation

60-years old man affected by cerebral anaplastic astrocytoma underwent subtotal neurosurgical excision and subsequent high-dose chemotherapy followed by autologous HSCT. During the post HSCT course, cranial irradiation and corticosteroids were administered as completion of therapeutic program.
At day +105 after HSCT, the patient developed HD, nodular sclerosis type, with polymorphic HD-like skin infiltration.

Conclusion

The clinical and pathological findings were consistent with the diagnosis of PTLD.
Appendix
Available only for authorised users
Literature
1.
go back to reference Swinnen LJ: Overview of posttransplant B-cell lymphoproliferative disorders. Semin Oncol. 1999, 26 (5 Suppl 14): 21-25.PubMed Swinnen LJ: Overview of posttransplant B-cell lymphoproliferative disorders. Semin Oncol. 1999, 26 (5 Suppl 14): 21-25.PubMed
2.
go back to reference Deeg J, Socie G: Malignancies after hematopoietic stem cell transplantation: many question, some answers. Blood. 1998, 91 (6): 1833-44.PubMed Deeg J, Socie G: Malignancies after hematopoietic stem cell transplantation: many question, some answers. Blood. 1998, 91 (6): 1833-44.PubMed
3.
go back to reference Baldanti F, Grossi P, Furione M, Simoncini L, Sarasini A, Comoli P, Maccario R, Fiocchi R, Gerna G: High levels of Epstein-Barr virus DNA in blood of solid-organ transplant recipients and their value in predicting posttransplant lymphoproliferative disorders. J Clin Microbiol. 2000, 38 (2): 613-9.PubMedPubMedCentral Baldanti F, Grossi P, Furione M, Simoncini L, Sarasini A, Comoli P, Maccario R, Fiocchi R, Gerna G: High levels of Epstein-Barr virus DNA in blood of solid-organ transplant recipients and their value in predicting posttransplant lymphoproliferative disorders. J Clin Microbiol. 2000, 38 (2): 613-9.PubMedPubMedCentral
4.
go back to reference Harris NL, Ferry JA, Swerdlow SH: Posttransplant lymphoproliferative disorders: summury of Society for Hematopathology Workshop. Semin Diagn Pathol. 1997, 14 (1): 8-14.PubMed Harris NL, Ferry JA, Swerdlow SH: Posttransplant lymphoproliferative disorders: summury of Society for Hematopathology Workshop. Semin Diagn Pathol. 1997, 14 (1): 8-14.PubMed
5.
go back to reference Rowlings PA, Curtis RE, Passweg JR, Deeg HJ, Socie G, Travis LB, Kingma DW, Jaffe ES, Sobocinski KA, Horowitz MM: Increased incidence of Hodgkin's disease after allogeneic bone marrow transplantation. J Clin Oncol. 1999, 17 (10): 3122-7.PubMed Rowlings PA, Curtis RE, Passweg JR, Deeg HJ, Socie G, Travis LB, Kingma DW, Jaffe ES, Sobocinski KA, Horowitz MM: Increased incidence of Hodgkin's disease after allogeneic bone marrow transplantation. J Clin Oncol. 1999, 17 (10): 3122-7.PubMed
6.
go back to reference Young L, Alfieri C, Hennessy K, Evans H, O'Hara C, Anderson KC, Ritz J, Shapiro RS, Rickinson A, Kieff E: Expression of Epstein-Barr virus transformation-associated genes in tissues of patients with EBV lymphoproliferative disease. N Engl J Med. 1989, 321 (16): 1080-5.CrossRefPubMed Young L, Alfieri C, Hennessy K, Evans H, O'Hara C, Anderson KC, Ritz J, Shapiro RS, Rickinson A, Kieff E: Expression of Epstein-Barr virus transformation-associated genes in tissues of patients with EBV lymphoproliferative disease. N Engl J Med. 1989, 321 (16): 1080-5.CrossRefPubMed
7.
go back to reference Chao NJ, Berry GJ, Advani R, Horning SJ, Weiss LM, Blume KG: Epstein-Barr virus-associated lymphoproliferative disorder following autologous bone marrow transplantation for non-Hodgkin's lymphoma. Transplantation. 1993, 55 (6): 1425-8.CrossRefPubMed Chao NJ, Berry GJ, Advani R, Horning SJ, Weiss LM, Blume KG: Epstein-Barr virus-associated lymphoproliferative disorder following autologous bone marrow transplantation for non-Hodgkin's lymphoma. Transplantation. 1993, 55 (6): 1425-8.CrossRefPubMed
8.
go back to reference Shepherd JD, Gascoyne RD, Barnett MJ, Coghlan JD, Phillips GL: Polyclonal Epstein-Barr virus-associated lymphoproliferative disorder following autografting for chronic myeloid leukemia. Bone Marrow Transplant. 1995, 15 (4): 639-41.PubMed Shepherd JD, Gascoyne RD, Barnett MJ, Coghlan JD, Phillips GL: Polyclonal Epstein-Barr virus-associated lymphoproliferative disorder following autografting for chronic myeloid leukemia. Bone Marrow Transplant. 1995, 15 (4): 639-41.PubMed
9.
go back to reference Briz M, Fores R, Regidor C, Busto MJ, Ramon y, Cajal S, Cabrera R, Diez JL, Sanjuan I, Fernandez MN: Epstein-Barr virus associated B-cell lymphoma after autologous bone marrow transplantation for T-cell acute lymphoblastic leukaemia. Br J Haematol. 1997, 98 (2): 485-7. 10.1046/j.1365-2141.1997.2153034.x.CrossRefPubMed Briz M, Fores R, Regidor C, Busto MJ, Ramon y, Cajal S, Cabrera R, Diez JL, Sanjuan I, Fernandez MN: Epstein-Barr virus associated B-cell lymphoma after autologous bone marrow transplantation for T-cell acute lymphoblastic leukaemia. Br J Haematol. 1997, 98 (2): 485-7. 10.1046/j.1365-2141.1997.2153034.x.CrossRefPubMed
10.
go back to reference Hauke RJ, Greiner TC, Smir BN, Vose JM, Tarantolo SR, Bashir RM, Bierman PJ: Epstein-Barr virus-associated lymphoproliferative disorder after autologous bone marrow transplantation: report of two cases. Bone Marrow Transplant. 1998, 21 (12): 1271-4. 10.1038/sj.bmt.1701258.CrossRefPubMed Hauke RJ, Greiner TC, Smir BN, Vose JM, Tarantolo SR, Bashir RM, Bierman PJ: Epstein-Barr virus-associated lymphoproliferative disorder after autologous bone marrow transplantation: report of two cases. Bone Marrow Transplant. 1998, 21 (12): 1271-4. 10.1038/sj.bmt.1701258.CrossRefPubMed
11.
go back to reference Lohrisch CA, Nevill TJ, Barnett MJ, Hogge DE, Connors JM, Keown PA, Gascoyne RD: Development of a biologically distinct EBV-related lymphoproliferative disorder following autologous bone marrow transplantation for an EBV-negative post-renal allograft Burkitt's lymphoma. Leuk Lymphoma. 2000, 39 (1–2): 195-201.CrossRefPubMed Lohrisch CA, Nevill TJ, Barnett MJ, Hogge DE, Connors JM, Keown PA, Gascoyne RD: Development of a biologically distinct EBV-related lymphoproliferative disorder following autologous bone marrow transplantation for an EBV-negative post-renal allograft Burkitt's lymphoma. Leuk Lymphoma. 2000, 39 (1–2): 195-201.CrossRefPubMed
12.
go back to reference Peniket AJ, Perry AR, Williams CD, MacMillan A, Watts MJ, Isaacson PG, Goldstone AH, Linch DC: A case of EBV-associated lymphoproliferative disease following high-dose therapy and CD34-purified autologous peripheral blood progenitor cell transplantation. Bone Marrow Transplant. 1998, 22 (3): 307-9. 10.1038/sj.bmt.1701335.CrossRefPubMed Peniket AJ, Perry AR, Williams CD, MacMillan A, Watts MJ, Isaacson PG, Goldstone AH, Linch DC: A case of EBV-associated lymphoproliferative disease following high-dose therapy and CD34-purified autologous peripheral blood progenitor cell transplantation. Bone Marrow Transplant. 1998, 22 (3): 307-9. 10.1038/sj.bmt.1701335.CrossRefPubMed
13.
go back to reference Yufu Y, Kimura M, Kawano R, Noguchi Y, Takatsuki H, Uike N, Ohshima K: EBV associated T cell lymphoproliferative disorder following autologous blood stem cell transplantation for relapsed Hodgkin's disease. Bone Marrow Transplant. 2000, 26 (12): 1339-41. 10.1038/sj.bmt.1702721.CrossRefPubMed Yufu Y, Kimura M, Kawano R, Noguchi Y, Takatsuki H, Uike N, Ohshima K: EBV associated T cell lymphoproliferative disorder following autologous blood stem cell transplantation for relapsed Hodgkin's disease. Bone Marrow Transplant. 2000, 26 (12): 1339-41. 10.1038/sj.bmt.1702721.CrossRefPubMed
14.
go back to reference Jenkins D, Difrancesco L, Chaudhry A, Morris D, Gluks S, Jones A, Woodman R, Brown CB, Russel J, Stewart DA: Successful traetment of post-transplantation lymphoproliferative disorder in autologous blood stem cell transplant recipients. Bone Marrow Transplant. 2002, 30 (5): 321-6. 10.1038/sj.bmt.1703603.CrossRefPubMed Jenkins D, Difrancesco L, Chaudhry A, Morris D, Gluks S, Jones A, Woodman R, Brown CB, Russel J, Stewart DA: Successful traetment of post-transplantation lymphoproliferative disorder in autologous blood stem cell transplant recipients. Bone Marrow Transplant. 2002, 30 (5): 321-6. 10.1038/sj.bmt.1703603.CrossRefPubMed
Metadata
Title
Hodgkin's disease as unusual presentation of post-transplant lymphoproliferative disorder after autologous hematopoietic cell transplantation for malignant glioma
Authors
Alberto Zambelli
Daniele Lilleri
Fausto Baldanti
Mario Scelsi
Laura Villani
Gian Antonio Da Prada
Publication date
01-12-2005
Publisher
BioMed Central
Published in
BMC Cancer / Issue 1/2005
Electronic ISSN: 1471-2407
DOI
https://doi.org/10.1186/1471-2407-5-109

Other articles of this Issue 1/2005

BMC Cancer 1/2005 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine